A row is brewing between the White House and Robert F Kennedy Jr after the Biden administration proposed making millions of ...
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and $11 billion for Medicaid over a decade. Total Medicare drug spending over ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The Biden administration is reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity ...
Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic co ...
The Biden-Harris Administration has proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and ...
The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...
Share of Amgen tumbled on Tuesday after the company's experimental weight-loss drug MariTide failed to meet lofty investor ...
The good news is that HHS recognizes that vitally important anti-obesity medicines like Wegovy and Zepbound should be made available to all Americans, regardless of income. The bad news is that unless ...
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback